亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

AML14.3D10 Cell Line

技術優勢: - Proprietary hematologic cell line - Ability to "switch" lineages and to produce GM-CSF in an autocrine fashion

技術應用: - Allergy Medications/Treatments- Asthma Medications/Treatments- Other Inflammatory Diseases

*Abstract: The inventors have developed a hematologic cell line that contributes to a better understanding of normal and malignant hematology. Their AML14 cell lineΓÇÖs AML14.3D10 subclone has become the standard cell line model for the study of eosinophils, white blood cells in the human immune system responsible for combating multicellular parasites and certain infections in vertebrates. Along with mast cells, these cells control mechanisms associated with allergy and asthma. The cell lines were established from leukemic populations and most commonly exhibit features analogous to those found in normal immature cells of the myeloid lineage. Some of these cell lines can be induced to a more mature phenotypical state through chemical or biologic exposure. The AML14.3D10 cell line has been used to obtain important new information relevant to eosinophil biology.

*Principal Investigation: Name: Michael Baumann
Department:

Name: Cassandra Paul
Department:

欲了解更多信息，請點擊這裡